Vineet Laboratories Limited (NSEI: VINEETLAB)
Health Care · Pharmaceuticals · IN
Rs37.45
+4.29% today · -11.1% 1Y
Vineet Laboratories Limited (NSEI: VINEETLAB) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $7.43M and employs 57 people.
Over the last twelve months the share price has lost 11.1%, trading between 27.96 and 49.99.
Tweenvest scores Vineet Laboratories Limited across four factors: quality 55/100, value 39/100, growth 0/100. Its strongest factor is quality.
VINEETLAB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $7.43M
- Revenue (TTM)
- $6.35M
- P/E
- 37.45
- EPS
- 1.00
- Dividend yield
- —
- Beta (5Y)
- 0.21
- 52-week high
- Rs49.99
- 52-week low
- Rs27.96
- Avg volume (3M)
- —
- Shares outstanding
- 19.21M
- Employees
- 57
- Next earnings
- —
About Vineet Laboratories Limited
Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid, 4-chlorobutyryl chloride, n-butyl magnesium chloride, 3-furaldehyde, 3-bromofuran, n-butylnitrite, ethyldiazo acetate, phenylboronic acid, 6-aminouracil, and 1-methyl-imidazole-2-carboxaldehyde. The company was incorporated in 2016 and is based in Hyderabad, India.
- ISIN
- INE505Y01010
- Founded
- 2016
- Listed since
- Jun 15, 2021
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Revive Therapeutics Ltd.CNSX: RVV | $7.79M | CA$0.03 | +25.00% |
| Sunil Healthcare LimitedBSE: 537253 | $7.68M | Rs72.50 | +6.30% |
| Protect Pharmaceutical CorporationOTCPK: PRTT | $7.47M | $0.13 | -23.53% |
| Source Natural Foods and Herbal Supplements LimitedBSE: 531398 | $7.47M | Rs112.25 | +4.52% |
| Pila Pharma AB (publ)OM: PILA | $7.38M | Skr1.62 | -7.18% |
| Incanthera plcOFEX: INC | $7.33M | £0.04 | -10.98% |
| Zenith Drugs LimitedNSEI: ZENITHDRUG | $7.19M | Rs40.60 | -3.45% |
| Onyx Biotec LimitedNSEI: ONYX | $7.12M | Rs38.00 | +1.20% |
Figures last refreshed Oct 11, 2026.